×
News Home

Avenue Therapeutics Inc (ATXI) has gained 261.36% in a Week, Should You Hold?

Monday, October 03, 2022 03:43 PM | InvestorsObserver Analysts
Avenue Therapeutics Inc (ATXI) has gained 261.36% in a Week, Should You Hold?

Avenue Therapeutics Inc (ATXI) is around the top of the Biotechnology industry according to InvestorsObserver. ATXI received an overall rating of 66, which means that it scores higher than 66 percent of all stocks. Avenue Therapeutics Inc also achieved a score of 72 in the Biotechnology industry, putting it above 72 percent of Biotechnology stocks. Biotechnology is ranked 14 out of the 148 industries.

Overall Score - 66
ATXI has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on ATXI!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Avenue Therapeutics Inc Stock Today?

Avenue Therapeutics Inc (ATXI) stock is trading at $12.72 as of 3:39 PM on Monday, Oct 3, a gain of $2.64, or 26.19% from the previous closing price of $10.08. The stock has traded between $12.30 and $15.51 so far today. Volume today is more active than usual. So far 15,421,092 shares have traded compared to average volume of 3,943,779 shares. Click Here to get the full Stock Report for Avenue Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App